Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients

PURPOSE: This study aimed to determine the oncologic efficacy of gonadotropin-releasing hormone (GnRH) agonist treatment concurrent with chemotherapy in a neoadjuvant setting. METHODS: A retrospective analysis was performed on 332 cases of invasive breast cancer in patients who were <40 years old...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee Jeong, Yoon, Tae-In, Chae, Hee Dong, Kim, Jeong Eun, Chae, Eun Young, Yu, Jong Han, Sohn, Guiyun, Ko, Beom Seok, Lee, Jong Won, Son, Byung Ho, Ahn, Sei Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705088/
https://www.ncbi.nlm.nih.gov/pubmed/26770243
http://dx.doi.org/10.4048/jbc.2015.18.4.365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705088/
https://www.ncbi.nlm.nih.gov/pubmed/26770243
http://dx.doi.org/10.4048/jbc.2015.18.4.365

Ejemplares similares